Showing 1 - 17 results of 17 for search 'Peter Robert Galle', query time: 0.08s
Refine Results
-
1
Comparison of the current international guidelines on the management of HCC by Friedrich Foerster, Peter Robert Galle
Published 2019-08-01
Article -
2
-
3
Impact of type 2 diabetes mellitus on results in the animal naming test in patients with and without liver cirrhosis. by Eva Maria Schleicher, Julia Tuchscher, Matthias Weber, Peter Robert Galle, Marcus-Alexander Wörns, Simon Johannes Gairing, Christian Labenz
Published 2025-01-01
Article -
4
-
5
-
6
Deficiency of the promyelocytic leukemia protein fosters hepatitis C-associated hepatocarcinogenesis in mice. by Kerstin Herzer, Anna Carbow, Svenja Sydor, Jan-Peter Sowa, Stefan Biesterfeld, Thomas-Georg Hofmann, Peter-Robert Galle, Guido Gerken, Ali Canbay
Published 2012-01-01
Article -
7
-
8
The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study. by Aline Mähringer-Kunz, Verena Steinle, Roman Kloeckner, Sebastian Schotten, Felix Hahn, Irene Schmidtmann, Jan Bernd Hinrichs, Christoph Düber, Peter Robert Galle, Hauke Lang, Arndt Weinmann
Published 2021-01-01
Article -
9
Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis by Simon Johannes Gairing, Julian Anders, Leonard Kaps, Michael Nagel, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Peter Robert Galle, Jörn M. Schattenberg, Marcus‐Alexander Wörns, Christian Labenz
Published 2022-05-01
Article -
10
The prognostic role of early tumor shrinkage in patients with hepatocellular carcinoma undergoing immunotherapy by Lukas Müller, Simon Johannes Gairing, Roman Kloeckner, Friedrich Foerster, Eva Maria Schleicher, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Moritz Christian Halfmann, Christoph Düber, Peter Robert Galle, Felix Hahn
Published 2022-09-01
Article -
11
Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I tri... by Markus Moehler, Annett Maderer, Anne Ehrlich, Friedrich Foerster, Arno Schad, Tanja Nickolay, Christian Ruckes, Arndt Weinmann, Visvakanth Sivanathan, Jens U. Marquardt, Peter Robert Galle, Marcus Woerns, Thomas Thomaidis
Published 2019-01-01
Article -
12
Six-Month Follow-Up after Vaccination with BNT162b2: SARS-CoV-2 Antigen-Specific Cellular and Humoral Immune Responses in Hemodialysis Patients and Kidney Transplant Recipients by Simone Cosima Boedecker-Lips, Anja Lautem, Stefan Runkel, Pascal Klimpke, Daniel Kraus, Philipp Keil, Stefan Holtz, Vanessa Tomalla, Paul Marczynski, Christian Benedikt Boedecker, Peter Robert Galle, Martina Koch, Julia Weinmann-Menke
Published 2022-01-01
Article -
13
Proton pump inhibitor use and risk of hepatic encephalopathy: A multicentre study by Simon Johannes Gairing, Chiara Mangini, Lisa Zarantonello, Elise Jonasson, Henrike Dobbermann, Philippe Sultanik, Peter Robert Galle, Joachim Labenz, Dominique Thabut, Jens Uwe Marquardt, Patricia P. Bloom, Mette Munk Lauridsen, Sara Montagnese, Christian Labenz
Published 2024-08-01
Article -
14
Cytokeratin-18 fragments predict treatment response and overall survival in gastric cancer in a randomized controlled trial by Michael Nagel, Julia Schulz, Annett Maderer, Katrin Goepfert, Nadine Gehrke, Thomas Thomaidis, Peter C Thuss-Patience, Salah E Al-Batran, Susanna Hegewisch-Becker, Peter Grimminger, Peter Robert Galle, Markus Möhler, Jörn Markus Schattenberg
Published 2018-03-01
Article -
15
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis by Simon Johannes Gairing, Sven Danneberg, Leonard Kaps, Michael Nagel, Eva Maria Schleicher, Charlotte Quack, Sinah Engel, Stefan Bittner, Peter Robert Galle, Jörn Markus Schattenberg, Marcus-Alexander Wörns, Felix Luessi, Jens Uwe Marquardt, Christian Labenz
Published 2023-04-01
Article -
16
Outcomes in patients receiving palliative chemotherapy for advanced biliary tract cancer by Felix Thol, Simon Johannes Gairing, Carolin Czauderna, Thomas Thomaidis, Thomas Gamstätter, Yvonne Huber, Johanna Vollmar, Johanna Lorenz, Maurice Michel, Fabian Bartsch, Lukas Müller, Roman Kloeckner, Peter Robert Galle, Marcus-Alexander Wörns, Jens Uwe Marquardt, Markus Moehler, Arndt Weinmann, Friedrich Foerster
Published 2022-03-01
Article -
17
Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab by Simon Johannes Gairing, Philipp Mildenberger, Jennifer Gile, Fabian Artusa, Bernhard Scheiner, Catherine Leyh, Sabine Lieb, Friedrich Sinner, Vincent Jörg, Thorben Fruendt, Vera Himmelsbach, Nada Abedin, Cennet Sahin, Katrin Böttcher, Jasmin Schuhbaur, Simon Labuhn, James Korolewicz, Claudia A.M. Fulgenzi, Antonio D'Alessio, Valentina Zanuso, Florian Hucke, Natascha Röhlen, Najib Ben Khaled, Eleonora Ramadori, Lukas Müller, Arndt Weinmann, Roman Kloeckner, Peter Robert Galle, Nguyen H. Tran, Sudhakar K. Venkatesh, Andreas Teufel, Matthias Ebert, Enrico N. De Toni, Dirk-Thomas Waldschmidt, Jens U. Marquardt, Dominik Bettinger, Markus Peck-Radosavljevic, Andreas Geier, Florian P. Reiter, Lorenza Rimassa, David J. Pinato, Christoph Roderburg, Thomas Ettrich, Michael Bitzer, Veit Scheble, Ursula Ehmer, Marie-Luise Berres, Fabian Finkelmeier, Maria Angeles Gonzalez-Carmona, Johann von Felden, Kornelius Schulze, Marino Venerito, Florian van Bömmel, Leonie S. Jochheim, Matthias Pinter, Raphael Mohr, Sumera I. Ilyas, Irene Schmidtmann, Friedrich Foerster
Published 2025-03-01
Article